CVS HEALTH CORPORATION CVS
$87.95
+1.76%
at last close
Analyst Consensus
- Consensus Rating
- Buy (17 Buy · 0 Hold · 0 Sell)
- Average Price Target
- $110.76
- Implied Upside
- +25.9%
- Price Target Range
- $91.00 – $125.00
- Analysts (12 mo)
- 17
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| 2026-09-03 | UBSKevin Caliendo |
Maintains | Buy | $126 → $118 |
| 2026-08-19 | Argus ResearchSteve Silver |
Maintains | Buy | $104 → $114 |
| 2026-08-12 | JP MorganLisa Gill |
Maintains | Overweight | $111 → $118 |
| 2026-08-06 | UBSKevin Caliendo |
Maintains | Buy | $122 → $126 |
| 2026-08-06 | Evercore ISI GroupElizabeth Anderson |
Maintains | Outperform | $130 → $125 |
| 2026-08-06 | BarclaysAndrew Mok |
Maintains | Overweight | $106 → $108 |
| 2026-07-24 | UBSKevin Caliendo |
Maintains | Buy | $115 → $122 |
| 2026-07-14 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $108 → $118 |
| 2026-07-13 | Wells FargoStephen Baxter |
Maintains | Overweight | $103 → $123 |
| 2026-07-09 | RBC CapitalBen Hendrix |
Maintains | Outperform | $107 → $113 |
| 2026-07-07 | Cantor FitzgeraldSarah James |
Maintains | Overweight | $100 → $110 |
| 2026-06-23 | B of A SecuritiesAllen Lutz |
Maintains | Buy | $100 → $110 |
| 2026-06-08 | MizuhoAnn Hynes |
Maintains | Outperform | $110 → $115 |
| 2026-06-04 | Morgan StanleyErin Wright |
Maintains | Overweight | $106 → $111 |
| 2026-06-01 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $102 → $108 |
| 2026-05-26 | BarclaysAndrew Mok |
Maintains | Overweight | $101 → $106 |
| 2026-05-20 | MizuhoAnn Hynes |
Maintains | Outperform | $102 → $110 |
| 2026-05-14 | Morgan StanleyErin Wright |
Maintains | Overweight | $93 → $106 |
| 2026-05-13 | BernsteinLance Wilkes |
Maintains | Outperform | $94 → $106 |
| 2026-05-12 | JP MorganLisa Gill |
Maintains | Overweight | $101 → $111 |
| 2026-05-11 | TD CowenCharles Rhyee |
Maintains | Buy | $105 → $110 |
| 2026-05-08 | Wells FargoStephen Baxter |
Maintains | Overweight | $102 → $103 |
| 2026-05-07 | UBSKevin Caliendo |
Maintains | Buy | $97 → $100 |
| 2026-05-07 | RBC CapitalBen Hendrix |
Maintains | Outperform | $93 → $107 |
| 2026-05-07 | BarclaysAndrew Mok |
Maintains | Overweight | $93 → $101 |
| 2026-05-07 | Truist SecuritiesDavid Macdonald |
Maintains | Buy | $98 → $102 |
| 2026-05-07 | Evercore ISI GroupElizabeth Anderson |
Maintains | Outperform | $100 → $105 |
| 2026-04-15 | BairdMichael Ha |
Maintains | Outperform | $92 → $94 |
| 2026-03-31 | Piper SandlerJessica Tassan |
Maintains | Overweight | $101 → $99 |
| 2026-03-12 | BernsteinLance Wilkes |
Upgrades | Market perform → Outperform | $91 → $94 |
Ratings and price targets reflect each firm's most recent published action. Consensus combines the latest call from every covering firm over the past 12 months; price targets are typically 12-month horizons.
Key Stats
- Last Close
- $87.95
- Market Cap
- $112.49 billion
- 52-Week Range
- $69.51 – $110.68
- Average Volume
- 7.81 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.